跳至主要内容
临床试验/EUCTR2012-003405-98-GB
EUCTR2012-003405-98-GB进行中(未招募)1 期

Developmental Clinical Studies - Reversing endometrial glucocorticoid deficiency in heavy menstrual bleeding - Dexamethasone for excessive menstrual bleeding

ACCORD University of Edinburgh0 个研究点目标入组 128 人开始时间: 2012年10月25日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Women will be invited to participate if they fulfil the following criteria: 1. with complaint of HMB, including women with fibroids 2. pre-menopausal 3. age 18 years and over 4. describing menstrual cycles every 21- 42 days 5. If of childbearing potential either agrees to practice a non-hormonal method of contraception for duration of study or has a partner with a vasectomy 6. Workup studies (1&2) – MBL for a single screening period is >= 50mL RCT (study 3) – average MBL for two screening menstrual collections is >= 50mL
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • Main exclusion criteria are: 1. A history or current uterus, cervix, ovarian or breast reproductive tract cancer 2. A known severe coagulation disorder 3. Glucocorticoid treatment or sex steroid administration by any route in previous 1 month 4. Thyroid, renal or liver dysfunction 5. Diabetes mellitus 6. Treated moderate/severe hypertension 7. Women with rare hereditary galactose intolerance, lactase deficiency or glucose galactose malabsorption (due to Lactose content of trial medication). 8. A problem with alcohol or drug abuse 9. A mental condition rendering the participant unable to understand the nature and scope of the study 10.Psychotic depressive illness 11.The subject is currently enrolled in an investigational drug or device study or participated in such a study within the previous 30 days and is still in exclusion period 12. Participation in treatment phase in any earlier DexFEM study (1 or 2). 13. The subject has been taking prohibited medication as detailed in protocol section 6.7.3 14. Currently breastfeeding 15. For workup study 1 there will be an additional exclusion criterion of any contra-indication to MRI (eg claustrophobic feelings.

研究者

发起方
ACCORD University of Edinburgh

相似试验